# Solid Biosciences Inc.: filings

SLDB · Nasdaq · CIK 1707502 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/sldb.md) · [Financials](/companies/sldb/financials.md) · [Filings](/companies/sldb/filings.md) · [Insiders](/companies/sldb/insiders.md)

## Reports and events: 154 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 336, 8-K 66, 3 38, 144 29, 10-Q 26, SC 13D/A 24, SC 13G/A 20, CORRESP 17, SC 13G 16, EFFECT 13, S-8 13, UPLOAD 13, S-3 12, DEFA14A 11, SCHEDULE 13D/A 10, 10-K 9, SCHEDULE 13G/A 9, DEF 14A 8, 424B5 6, 4/A 6, ARS 4, PRE 14A 4, SC 13D 4, SCHEDULE 13G 4, D 3, S-1/A 3, 8-K/A 2, DRSLTR 2, FWP 2, S-3/A 2, SEC STAFF LETTER 2, 10-K/A 1, 144/A 1, 3/A 1, 424B3 1, 424B4 1, 424B7 1, 8-A12B 1, CERT 1, CT ORDER 1, DEFM14A 1, DRS 1, DRS/A 1, PREM14A 1, S-1 1, S-1MEF 1, S-3ASR 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-14 | 17:22 ET | [SCHEDULE 13D/A](/filings/0001193125-26-352656.md) | Ownership report, active investor, amended | 0001193125-26-352656 |
| 2026-08-06 | 17:15 ET | [8-K](/filings/0001193125-26-338438.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-338438 |
| 2026-08-06 | 16:04 ET | [10-Q](/filings/0001193125-26-337935.md) | Quarterly report, period 2026-06-30 | 0001193125-26-337935 |
| 2026-06-24 | 18:49 ET | [SCHEDULE 13D/A](/filings/0001346824-26-000183.md) | Ownership report, active investor, amended | 0001346824-26-000183 |
| 2026-06-10 | 16:05 ET | [8-K](/filings/0001193125-26-265804.md) | 5.07 Shareholder vote results | 0001193125-26-265804 |
| 2026-05-12 | 16:02 ET | [10-Q](/filings/0001193125-26-219337.md) | Quarterly report, period 2026-03-31 | 0001193125-26-219337 |
| 2026-04-23 | 16:03 ET | [DEF 14A](/filings/0001193125-26-173642.md) | Proxy statement, period 2026-06-10 | 0001193125-26-173642 |
| 2026-04-10 | 16:09 ET | [8-K](/filings/0001193125-26-151259.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-151259 |
| 2026-03-19 | 16:01 ET | [10-K](/filings/0001193125-26-115928.md) | Annual report, period 2025-12-31 | 0001193125-26-115928 |
| 2026-03-17 | 18:50 ET | [SCHEDULE 13D/A](/filings/0001104659-26-029671.md) | Ownership report, active investor, amended | 0001104659-26-029671 |
| 2026-03-12 | 17:34 ET | [8-K](/filings/0001193125-26-102489.md) | 7.01 Regulation FD disclosure; 8.01 Other events | 0001193125-26-102489 |
| 2026-03-11 | 16:00 ET | [SCHEDULE 13D/A](/filings/0001193125-26-102083.md) | Ownership report, active investor, amended | 0001193125-26-102083 |
| 2026-03-10 | 17:00 ET | [SCHEDULE 13D/A](/filings/0001193125-26-100348.md) | Ownership report, active investor, amended | 0001193125-26-100348 |
| 2026-03-10 | 16:38 ET | [SCHEDULE 13D/A](/filings/0001346824-26-000070.md) | Ownership report, active investor, amended | 0001346824-26-000070 |
| 2026-03-06 | 16:36 ET | [8-K](/filings/0001193125-26-096709.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-096709 |
| 2025-11-03 | 17:22 ET | [10-Q](/filings/0001193125-25-262818.md) | Quarterly report, period 2025-09-30 | 0001193125-25-262818 |
| 2025-11-03 | 17:15 ET | [8-K](/filings/0001193125-25-262795.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-262795 |
| 2025-08-14 | 18:06 ET | [SCHEDULE 13D/A](/filings/0001415889-25-022028.md) | Ownership report, active investor, amended | 0001415889-25-022028 |
| 2025-08-12 | 16:03 ET | [10-Q](/filings/0000950170-25-107279.md) | Quarterly report, period 2025-06-30 | 0000950170-25-107279 |
| 2025-06-13 | 16:21 ET | [8-K](/filings/0000950170-25-086215.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000950170-25-086215 |
| 2025-05-15 | 16:49 ET | [8-K](/filings/0000950170-25-072792.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-072792 |
| 2025-05-15 | 16:04 ET | [10-Q](/filings/0000950170-25-072560.md) | Quarterly report, period 2025-03-31 | 0000950170-25-072560 |
| 2025-04-25 | 16:01 ET | [DEF 14A](/filings/0001193125-25-096695.md) | Proxy statement, period 2025-06-12 | 0001193125-25-096695 |
| 2025-03-06 | 16:13 ET | [10-K](/filings/0000950170-25-034644.md) | Annual report, period 2024-12-31 | 0000950170-25-034644 |
| 2025-02-21 | 18:04 ET | [SCHEDULE 13D/A](/filings/0000950170-25-025036.md) | Ownership report, active investor, amended | 0000950170-25-025036 |
| 2025-02-21 | 16:15 ET | [SCHEDULE 13D/A](/filings/0001415889-25-005065.md) | Ownership report, active investor, amended | 0001415889-25-005065 |
| 2025-02-21 | 16:15 ET | [SCHEDULE 13D/A](/filings/0000950170-25-024858.md) | Ownership report, active investor, amended | 0000950170-25-024858 |
| 2025-02-18 | 16:52 ET | [8-K](/filings/0001193125-25-028691.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-028691 |
| 2025-02-18 | 07:07 ET | [8-K](/filings/0001193125-25-028146.md) | 8.01 Other events | 0001193125-25-028146 |
| 2025-02-18 | 06:55 ET | [8-K](/filings/0001193125-25-028123.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-028123 |
| 2024-11-14 | 19:59 ET | [SC 13D/A](/filings/0001193125-24-259014.md) | Ownership report, active investor, amended | 0001193125-24-259014 |
| 2024-11-06 | 16:02 ET | [10-Q](/filings/0000950170-24-122247.md) | Quarterly report, period 2024-09-30 | 0000950170-24-122247 |
| 2024-08-13 | 16:01 ET | [10-Q](/filings/0000950170-24-096130.md) | Quarterly report, period 2024-06-30 | 0000950170-24-096130 |
| 2024-06-12 | 18:26 ET | [SC 13D/A](/filings/0001104659-24-070940.md) | Ownership report, active investor, amended | 0001104659-24-070940 |
| 2024-06-11 | 20:43 ET | [SC 13D/A](/filings/0001193125-24-159367.md) | Ownership report, active investor, amended | 0001193125-24-159367 |
| 2024-06-11 | 16:22 ET | [8-K](/filings/0001193125-24-159143.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-24-159143 |
| 2024-05-15 | 07:30 ET | [10-Q](/filings/0000950170-24-060034.md) | Quarterly report, period 2024-03-31 | 0000950170-24-060034 |
| 2024-04-26 | 16:14 ET | [DEF 14A](/filings/0001193125-24-118079.md) | Proxy statement, period 2024-06-11 | 0001193125-24-118079 |
| 2024-03-13 | 07:30 ET | [10-K](/filings/0000950170-24-030508.md) | Annual report, period 2023-12-31 | 0000950170-24-030508 |
| 2024-01-12 | 17:11 ET | [SC 13D/A](/filings/0001193125-24-007643.md) | Ownership report, active investor, amended | 0001193125-24-007643 |
| 2024-01-12 | 17:05 ET | [SC 13D/A](/filings/0001193125-24-007632.md) | Ownership report, active investor, amended | 0001193125-24-007632 |
| 2024-01-11 | 17:24 ET | [SC 13D/A](/filings/0001104659-24-003373.md) | Ownership report, active investor, amended | 0001104659-24-003373 |
| 2024-01-10 | 16:31 ET | [SC 13D/A](/filings/0001193125-24-005969.md) | Ownership report, active investor, amended | 0001193125-24-005969 |
| 2024-01-08 | 07:24 ET | [8-K](/filings/0001193125-24-003882.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-003882 |
| 2023-11-15 | 07:59 ET | [8-K](/filings/0001193125-23-277552.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-277552 |
| 2023-11-08 | 16:08 ET | [10-Q](/filings/0000950170-23-061096.md) | Quarterly report, period 2023-09-30 | 0000950170-23-061096 |
| 2023-08-14 | 16:03 ET | [10-Q](/filings/0000950170-23-042371.md) | Quarterly report, period 2023-06-30 | 0000950170-23-042371 |
| 2023-06-09 | 16:30 ET | [8-K](/filings/0001193125-23-164486.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-23-164486 |
| 2023-05-22 | 16:31 ET | [8-K](/filings/0001193125-23-150518.md) | 5.02 Departure or appointment of officers or directors | 0001193125-23-150518 |
| 2023-05-11 | 07:41 ET | [10-Q](/filings/0000950170-23-020851.md) | Quarterly report, period 2023-03-31 | 0000950170-23-020851 |

Page 1 of 4. [Older](/companies/sldb/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 26, 2026, 16:06 ET. No prices; not investment advice.